Mithra Pharmaceuticals SA
XBRU:MITRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mithra Pharmaceuticals SA
XBRU:MITRA
|
BE |
|
Bitcoin Group SE
XETRA:ADE
|
DE |
|
E
|
Emimen Co Ltd
TSE:9237
|
JP |
|
L
|
Lambo Group Bhd
KLSE:LAMBO
|
MY |
|
Mediaone Global Entertainment Ltd
BSE:503685
|
IN |
|
MS&AD Insurance Group Holdings Inc
TSE:8725
|
JP |
|
G
|
GoldMoney Inc
OTC:XAUMF
|
CA |
|
M
|
Minda Global Bhd
KLSE:MINDA
|
MY |
|
A
|
Asia Holdings Co Ltd
KRX:002030
|
KR |
|
N
|
Nedbank Group Ltd
JSE:NED
|
ZA |
|
National Plastic Industries Ltd
BSE:526616
|
IN |
|
Holders Technology PLC
LSE:HDT
|
UK |
Bankruptcy Probability
Mithra Pharmaceuticals SA's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mithra Pharmaceuticals SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BE |
|
Mithra Pharmaceuticals SA
XBRU:MITRA
|
14.9m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mithra Pharmaceuticals SA's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mithra Pharmaceuticals SA has total debt of 179.2m EUR. This includes both short-term (0 EUR) and long-term (179.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
